Tumour necrosis factor-α regulates human eosinophil apoptosis via ligation of TNF-receptor 1 and balance between NF-κB and AP-1.
Tumour necrosis factor-α regulates human eosinophil apoptosis via ligation of TNF-receptor 1 and balance between NF-κB and AP-1.
复制标题
DOI:
10.1371/journal.pone.0090298
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Moilanen E
中科院分区:
文献类型:
--
作者:
Kankaanranta H;Ilmarinen P;Zhang X;Adcock IM;Lahti A;Barnes PJ;Giembycz MA;Lindsay MA;Moilanen E
Eosinophils play a central role in asthma. The present study was performed to investigate the effect of tumour necrosis factor-α (TNF-α) on longevity of isolated human eosinophils. In contrast to Fas, TNF-α inhibited eosinophil apoptosis as evidenced by a combination of flow cytometry, DNA fragmentation assay and morphological analyses. The effect of TNF-α on eosinophil apoptosis was reversed by a TNF-α neutralising antibody. The anti-apoptotic effect of TNF-α was not due to autocrine release of known survival-prolonging cytokines interleukins 3 and 5 or granulocyte-macrophage-colony-stimulating factor as their neutralisation did not affect the effect of TNF-α. The anti-apoptotic signal was mediated mainly by the TNF-receptor 1. TNF-α induced phosphorylation and degradation of IκB and an increase in NF-κB DNA-binding activity. The survival-prolonging effect of TNF-α was reversed by inhibitors of NF-κB pyrrolidinedithiocarbamate and gliotoxin and by an inhibitor of IκB kinase, BMS-345541. TNF-α induced also an increase in AP-1 DNA-binding activity and the antiapoptotic effect of TNF-α was potentiated by inhibitors of AP-1, SR 11302 and tanshinone IIA and by an inhibitor of c-jun-N-terminal kinase, SP600125, which is an upstream kinase activating AP-1. Our results thus suggest that TNF-α delays human eosinophil apoptosis via TNF-receptor 1 and the resulting changes in longevity depend on yin-yang balance between activation of NF-κB and AP-1.
登录
查看更多内容
影响因子:
3.6
作者:
Lahti, A;Jalonen, U;Moilanen, E
通讯作者:
Moilanen, E
DOI:
10.2174/1568010054526395
发表时间:
2005-08-01
期刊:
Current Drug Targets - Inflammation and Allergy
影响因子:
--
作者:
Kankaanranta, Hannu;Moilanen, Eeva;Zhang, Xianzhi
通讯作者:
Zhang, Xianzhi
DOI:
10.1016/j.jaci.2007.10.028
发表时间:
2008-01
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
Brightling C;Berry M;Amrani Y
通讯作者:
Amrani Y
影响因子:
64.8
作者:
De Smaele, E;Zazzeroni, F;Franzoso, G
通讯作者:
Franzoso, G
影响因子:
20.3
作者:
Druilhe, A;Cai, ZZ;Pretolani, M
通讯作者:
Pretolani, M